HMGB1 and necrotizing enterocolitis: Additionally, the administration of the HMGB1 inhibitor glycyrrhizin inhibited the TLR4/NF‐κB signaling pathway and thereby inhibited NLRP3, ultimately alleviating intestinal inflammation in NEC.54